Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: Modulation by the Nrf2/Trx axis

Free Radical Biology and Medicine

Volumn 48, Issue 10, 2010, Pages 1370-1381

  Niso Santano, Mireia ^a   González Polo, Rosa A ^a   Bravo San Pedro, José M ^a   Gómez Sánchez, Rubén ^a   Lastres Becker, Isabel ^b   Ortiz Ortiz, Miguel A ^a   Soler, Germán ^a   Morán, José M ^a   Cuadrado, Antonio ^b   Fuentes, José M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Cell death; Free radicals; Herbicide; Nrf2 deficient; Stress signaling

Indexed keywords

ALPHA TOCOPHEROL; APOPTOSIS SIGNAL REGULATING KINASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PARAQUAT; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG TARGETING; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

PARKINSONIA;

EID: 77951939611     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.024     Document Type: Article

References (72)

1. Chinta S.J., Rane A., Poksay K.S., Bredesen D.E., Andersen J.K., Rao R.V. Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquat. Neuromol. Med. 2008, 10:333-342.
2. Dick S., Semple S., Dick F., Seaton A. Occupational titles as risk factors for Parkinson's disease. Occup. Med. (London) 2007, 57:50-56.
3. Hertzman C., Wiens M., Bowering D., Snow B., Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind. Med. 1990, 17:349-355.
4. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997, 48:1583-1588.
5. Holtz W.A., O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 2003, 278:19367-19377.
6. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 2002, 10:119-127.
7. McCormack A.L., Di Monte D.A. Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J. Neurochem. 2003, 85:82-86.
8. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., Di Monte D.A. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 2005, 93:1030-1037.
9. Peng J., Mao X.O., Stevenson F.F., Hsu M., Andersen J.K. The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J. Biol. Chem. 2004, 279:32626-32632.
10. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 2002, 22:10690-10698.
11. Gonzalez-Polo R.A., Rodriguez-Martin A., Moran J.M., Niso M., Soler G., Fuentes J.M. Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res. 2004, 1011:170-176.
12. Gonzalez-Polo R.A., Niso-Santano M., Ortiz-Ortiz M.A., Gomez-Martin A., Moran J.M., Garcia-Rubio L., et al. Relationship between autophagy and apoptotic cell death in human neuroblastoma cells treated with paraquat: could autophagy be a "brake" in paraquat-induced apoptotic death?. Autophagy 2007, 3:366-367.
13. Gonzalez-Polo R.A., Niso-Santano M., Ortiz-Ortiz M.A., Gomez-Martin A., Moran J.M., Garcia-Rubio L., et al. Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol. Sci. 2007, 97:448-458.
14. Cappelletti G., Maggioni M.G., Maci R. Apoptosis in human lung epithelial cells: triggering by paraquat and modulation by antioxidants. Cell Biol. Int. 1998, 22:671-678.
15. Fei Q., McCormack A.L., Di Monte D.A., Ethell D.W. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J. Biol. Chem. 2008, 283:3357-3364.
16. Niso-Santano M., Moran J.M., Garcia-Rubio L., Gomez-Martin A., Gonzalez-Polo R.A., Soler G., et al. Low concentrations of paraquat induces early activation of extracellular signal-regulated kinase 1/2, protein kinase B, and c-Jun N-terminal kinase 1/2 pathways: role of c-Jun N-terminal kinase in paraquat-induced cell death. Toxicol. Sci. 2006, 92:507-515.
17. Klintworth H., Newhouse K., Li T., Choi W.S., Faigle R., Xia Z. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. Toxicol. Sci. 2007, 97:149-162.
18. Yang W., Tiffany-Castiglioni E. Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria. J. Toxicol. Environ. Health A 2008, 71:289-299.
19. Alexi T., Borlongan C.V., Faull R.L., Williams C.E., Clark R.G., Gluckman P.D., et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog. Neurobiol. 2000, 60:409-470.
20. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
21. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 1999, 57:301-323.
22. Chen L., Liu L., Huang S. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic. Biol. Med. 2008, 45:1035-1044.
23. Jellinger K.A. Cell death mechanisms in Parkinson's disease. J. Neural Transm. 2000, 107:1-29.
24. Ruffels J., Griffin M., Dickenson J.M. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death. Eur. J. Pharmacol. 2004, 483:163-173.
25. Wu D.C., Re D.B., Nagai M., Ischiropoulos H., Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. USA 2006, 103:12132-12137.
26. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 2000, 7:240-250.
27. Burke R.E., Kholodilov N.G. Programmed cell death: does it play a role in Parkinson's disease?. Ann. Neurol. 1998, 44:S126-S133.
28. Honig L.S., Rosenberg R.N. Apoptosis and neurologic disease. Am. J. Med. 2000, 108:317-330.
29. Ichijo H., Nishida E., Irie K., Ten Dijke P., Saitoh M., Moriguchi T., et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90-94.
30. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 1999, 18:6087-6093.
31. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17:2596-2606.
32. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002, 16:1345-1355.
33. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 1998, 2:389-395.
34. Takeda K., Matsuzawa A., Nishitoh H., Tobiume K., Kishida S., Ninomiya-Tsuji J., et al. Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation. EMBO Rep. 2004, 5:161-166.
35. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
36. Sarker K.P., Biswas K.K., Yamakuchi M., Lee K.Y., Hahiguchi T., Kracht M., et al. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J. Neurochem. 2003, 85:50-61.
37. Sarker K.P., Biswas K.K., Rosales J.L., Yamaji K., Hashiguchi T., Lee K.Y., et al. Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. J. Neurochem. 2003, 87:1345-1353.
38. Machino T., Hashimoto S., Maruoka S., Gon Y., Hayashi S., Mizumura K., et al. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates hydrogen peroxide-induced apoptosis in human pulmonary vascular endothelial cells. Crit. Care Med. 2003, 31:2776-2781.
39. Saeki K., Kobayashi N., Inazawa Y., Zhang H., Nishitoh H., Ichijo H., et al. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem. J. 2002, 368:705-720.
40. Van Laethem A., Nys K., Van Kelst S., Claerhout S., Ichijo H., Vandenheede J.R., et al. Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Free Radic. Biol. Med. 2006, 41:1361-1371.
41. Copple I.M., Goldring C.E., Kitteringham N.R., Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 2008, 246:24-33.
42. Yu X., Kensler T. Nrf2 as a target for cancer chemoprevention. Mutat. Res. 2005, 591:93-102.
43. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
44. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 2004, 24:8477-8486.
45. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 2004, 24:10941-10953.
46. Yamamoto N., Sawada H., Izumi Y., Kume T., Katsuki H., Shimohama S., et al. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J. Biol. Chem. 2007, 282:4364-4372.
47. Kim Y.C., Masutani H., Yamaguchi Y., Itoh K., Yamamoto M., Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2: a differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 2001, 276:18399-18406.
48. Kim Y.C., Yamaguchi Y., Kondo N., Masutani H., Yodoi J. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 2003, 22:1860-1865.
49. Burton N.C., Kensler T.W., Guilarte T.R. In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 2006, 27:1094-1100.
50. Chen P.C., Vargas M.R., Pani A.K., Smeyne R.J., Johnson D.A., Kan Y.W., et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. USA 2009, 106:2933-2938.
51. Innamorato N.G., Lastres-Becker I., Cuadrado A. Role of microglial redox balance in modulation of neuroinflammation. Curr. Opin. Neurol. 2009, 22:308-314.
52. Cuadrado A., Moreno-Murciano P., Pedraza-Chaverri J. The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease. Expert Opin. Ther. Targets 2009, 13:319-329.
53. Cuadrado A., Rojo A.I. Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr. Pharm. Des. 2008, 14:429-442.
54. Mattson M.P., Son T.G., Camandola S. Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 2007, 5:174-186.
55. Rojo A.I., Innamorato N.G., Martin-Moreno A.M., De Ceballos M.L., Yamamoto M., Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 2009, 58:588-598.
56. Innamorato N.G., Rojo A.I., Garcia-Yague A.J., Yamamoto M., De Ceballos M.L., Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 2008, 181:680-689.
57. Zhao J., Kobori N., Aronowski J., Dash P.K. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett. 2006, 393:108-112.
58. Han J.M., Lee Y.J., Lee S.Y., Kim E.M., Moon Y., Kim H.W., et al. Protective effect of sulforaphane against dopaminergic cell death. J. Pharmacol. Exp. Ther. 2007, 321:249-256.
59. Satoh T., Harada N., Hosoya T., Tohyama K., Yamamoto M., Itoh K. Keap1/Nrf2 system regulates neuronal survival as revealed through study of Keap1 gene-knockout mice. Biochem. Biophys. Res. Commun. 2009, 380:298-302.
60. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
61. Gonzalez-Polo R.A., Carvalho G., Braun T., Decaudin D., Fabre C., Larochette N., et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 2005, 24:7503-7513.
62. Gonzalez-Polo R.A., Boya P., Pauleau A.L., Jalil A., Larochette N., Souquere S., et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 2005, 118:3091-3102.
63. Fuentes J.M., Lompre A.M., Moller J.V., Falson P., le Maire M. Clean Western blots of membrane proteins after yeast heterologous expression following a shortened version of the method of Perini et al. Anal. Biochem. 2000, 285:276-278.
64. Cristovao A.C., Choi D., Baltazar G., Beal F., Kim Y.S. The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid. Redox Signaling 2009, 11:2105-2118.
65. Ouyang M., Shen X. Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurochem. 2006, 97:234-244.
66. Zaidi A., Fernandes D., Bean J.L., Michaelis M.L. Effects of paraquat-induced oxidative stress on the neuronal plasma membrane Ca2+-ATPase. Free Radic. Biol. Med. 2009, 47:1507-1514.
67. Kitazawa Y., Matsubara M., Takeyama N., Tanaka T. The role of xanthine oxidase in paraquat intoxication. Arch. Biochem. Biophys. 1991, 288:220-224.
68. Sakai M., Yamagami K., Kitazawa Y., Takeyama N., Tanaka T. Xanthine oxidase mediates paraquat-induced toxicity on cultured endothelial cell. Pharmacol. Toxicol. 1995, 77:36-40.
69. Hattori K., Naguro I., Runchel C., Ichijo H. The roles of ASK family proteins in stress responses and diseases. Cell Commun. Signaling 2009, 7:9.
70. Pham D.Q., Plakogiannis R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract, Part 2. Ann. Pharmacother. 2005, 39:2065-2072.
71. Weber C.A., Ernst M.E. Antioxidants, supplements, and Parkinson's disease. Ann. Pharmacother. 2006, 40:935-938.
72. Wolfrath S.C., Borenstein A.R., Schwartz S., Hauser R.A., Sullivan K.L., Zesiewicz T.A. Use of nutritional supplements in Parkinson's disease patients. Mov. Disord. 2006, 21:1098-1101.